Literature DB >> 31385320

Genetic variation influencing hemoglobin levels and risk for anemia across populations.

Paloma K Barrera-Reyes1,2, M Elizabeth Tejero1.   

Abstract

Hemoglobin (Hb) concentration is the outcome of the interaction between genetic variation and environmental factors, including nutritional status, sex, age, and altitude. Genetic diversity influencing this protein is complex and varies widely across populations. Variants related to abnormal Hb or altered characteristics of the erythrocytes increase the risk for anemia. The most prevalent are related to the inherited globin abnormalities affecting Hb production and structure. Malaria-endemic regions harbor the highest frequencies of variants associated with the most frequent monogenic diseases and the risk for nonnutritional anemia and are considered as public health problems. Variation in genes encoding for enzymes and membrane proteins in red blood cells also influence erythrocyte life span and risk for anemia. Most of these variants are rare. Interindividual variability of hematological parameters is also influenced by common genetic variation across the whole genome. Some of the identified variants are associated with Hb production, erythropoiesis, and iron metabolism. Specialized databases have been developed to organize and update the large body of available information on genetic variation related to Hb variation, their frequency, geographical distribution, and clinical significance. Our present review analyzed the underlying genetic factors that affect Hb concentrations, their clinical relevance, and geographical distribution across populations.
© 2019 New York Academy of Sciences. The World Health Organization retains copyright and all other rights in the manuscript of this article as submitted for publication.

Entities:  

Keywords:  anemia; genetics; hemoglobin; hemoglobinopathies

Year:  2019        PMID: 31385320     DOI: 10.1111/nyas.14200

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

Review 1.  HbA1C as a marker of retrograde glycaemic control in diabetes patient with co-existed beta-thalassaemia: A case report and a literature review.

Authors:  Zoran Gluvic; Milan Obradovic; Milena Lackovic; Vladimir Samardzic; Jelena Tica Jevtic; Magbubah Essack; Vladimir B Bajic; Esma R Isenovic
Journal:  J Clin Pharm Ther       Date:  2019-11-17       Impact factor: 2.512

2.  Risk Association, Linkage Disequilibrium, and Haplotype Analyses of β-Like Globin Gene Polymorphisms with Malaria Risk in the Sabah Population of Malaysian Borneo.

Authors:  Eric Tzyy Jiann Chong; Lucky Poh Wah Goh; Ho Jin Yap; Eric Wei Choong Yong; Ping-Chin Lee
Journal:  Genes (Basel)       Date:  2022-07-11       Impact factor: 4.141

3.  PTD-mediated delivery of α-globin chain into Κ-562 erythroleukemia cells and α-thalassemic (HBH) patients' RBCs ex vivo in the frame of Protein Replacement Therapy.

Authors:  Androulla N Miliotou; Dionysia Papagiannopoulou; Efthymia Vlachaki; Martina Samiotaki; Dimitra Laspa; Stamatia Theodoridou; Asterios S Tsiftsoglou; Lefkothea C Papadopoulou
Journal:  J Biol Res (Thessalon)       Date:  2021-07-20       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.